Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis

Enciu, Vlad-Teodor; Ologeanu, Priscila Mădălina; Constantinescu, Alexandru; Fierbinteanu-Braticevici, Carmen

doi:10.2478/rjim-2025-0007

Abstract

Alcohol-related liver disease (ALD) is still to this date one of the leading causes of chronic liver disease globally. ALD comprises a wide disease spectrum, from the benign liver steatosis, to the life-threatening inflammatory acute phenotype of alcoholic hepatitis (AH) and ultimately, advanced liver fibrosis and cirrhosis. AH represents an acute inflammatory liver condition caused by prolonged high quantities of alcohol intake. Disease outcome varies from mild to severe, with systemic implication and high mortality. Although the pathogenesis has been extensively studied over the years, little progress has been made regarding therapeutic options. In over 50 years, steroid treatment is still the cornerstone therapeutic option, albeit having multiple limitations and a low success rate. On the other hand, important progress has been made regarding disease management and severity stratification with the implementation of different prognostic score. Although highly prevalent, AH still has many unmet needs, with a growing necessity for novel non-invasive diagnosis, prognosis biomarkers and impactful treatment options.

References

M. Ventura-Cots, M. P. Ballester-Ferré, S. Ravi, and R. Bataller, “Public health policies and alcohol-related liver disease,” JHEP Rep., vol. 1, no. 5, pp. 403–413, Aug. 2019, doi: 10.1016/j.jhepr.2019.07.009.
Open DOI Search in Google Scholar Back to article
M. Hernandez-Tejero, A. Clemente-Sanchez, and R. Bataller, “Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease,” J. Clin. Exp. Hepatol., vol. 13, no. 1, pp. 75–87, 2023, doi: 10.1016/j.jceh.2022.10.002.
Open DOI Search in Google Scholar Back to article
A. K. Singal and P. Mathurin, “Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review,” JAMA, vol. 326, no. 2, pp. 165–176, Jul. 2021, doi: 10.1001/jama.2021.7683.
Open DOI Search in Google Scholar Back to article
N. Hosseini, J. Shor, and G. Szabo, “Alcoholic Hepatitis: A Review,” Alcohol Alcohol. Oxf. Oxfs., vol. 54, no. 4, pp. 408–416, Jul. 2019, doi: 10.1093/alcalc/agz036.
Open DOI Search in Google Scholar Back to article
R. Bataller, J. P. Arab, and V. H. Shah, “Alcohol-Associated Hepatitis,” N. Engl. J. Med., vol. 387, no. 26, pp. 2436–2448, Dec. 2022, doi: 10.1056/NEJMra2207599.
Open DOI Search in Google Scholar Back to article
E. Rahimi and J.-J. Pan, “Prognostic models for alcoholic hepatitis,” Biomark. Res., vol. 3, p. 20, Jul. 2015, doi: 10.1186/s40364-015-0046-z.
Open DOI Search in Google Scholar Back to article
V.-T. Enciu, P. M. Ologeanu, A.-M. Călin-Necula, A. C. Moldoveanu, G. Oprea-Călin, and C. Fierbinţeanu-Braticevici, “Model of disease severity in alcoholic hepatitis and novel prognostic insights,” Romanian J. Intern. Med. Rev. Roum. Med. Interne, vol. 62, no. 2, pp. 194–202, Jun. 2024, doi: 10.2478/rjim-2024-0001.
Open DOI Search in Google Scholar Back to article
M. A. Healey et al., “Utility of Lille Score in Predicting 30-Day Survival in Steroid-Treated Alcohol-Associated Hepatitis,” Dig. Dis. Sci., vol. 69, no. 8, pp. 3043–3050, Aug. 2024, doi: 10.1007/s10620-024-08479-6.
Open DOI Search in Google Scholar Back to article
L. A. Díaz et al., “MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis,” JHEP Rep. Innov. Hepatol., vol. 5, no. 8, p. 100727, Aug. 2023, doi: 10.1016/j.jhepr.2023.100727.
Open DOI Search in Google Scholar Back to article
W. C. Maddrey, J. K. Boitnott, M. S. Bedine, F. L. Weber, E. Mezey, and R. I. White, “Corticosteroid therapy of alcoholic hepatitis,” Gastroenterology, vol. 75, no. 2, pp. 193–199, Aug. 1978.
Search in Google Scholar Back to article
E. Nguyen-Khac et al., “Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis,” N. Engl. J. Med., vol. 365, no. 19, pp. 1781–1789, Nov. 2011, doi: 10.1056/NEJMoa1101214.
Open DOI Search in Google Scholar Back to article
M. Thursz et al., “EASL Clinical Practice Guidelines: Management of alcohol-related liver disease,” J. Hepatol., vol. 69, no. 1, pp. 154–181, Jul. 2018, doi: 10.1016/j.jhep.2018.03.018.
Open DOI Search in Google Scholar Back to article
M. E. Rinella et al., “A multisociety Delphi consensus statement on new fatty liver disease nomenclature,” J. Hepatol., vol. 79, no. 6, pp. 1542–1556, Dec. 2023, doi: 10.1016/j.jhep.2023.06.003.
Open DOI Search in Google Scholar Back to article
“Hepahealth II,” EASL-The Home of Hepatology. Accessed: Dec. 02, 2024. [Online]. Available: https://easl.eu/hepahealth-ii/
Search in Google Scholar Back to article
M. A. Avila et al., “Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting,” Gut, vol. 69, no. 4, pp. 764–780, Apr. 2020, doi: 10.1136/gutjnl-2019-319720.
Open DOI Search in Google Scholar Back to article
“Alcohol’s Effects on the Body | National Institute on Alcohol Abuse and Alcoholism (NIAAA).” Accessed: Jan. 28, 2025. [Online]. Available: https://www.niaaa.nih.gov/alcohols-effects-health/alcohols-effects-body
Search in Google Scholar Back to article
M. Roerecke et al., “Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis,” Am. J. Gastroenterol., vol. 114, no. 10, pp. 1574–1586, Oct. 2019, doi: 10.14309/ajg.0000000000000340.
Open DOI Search in Google Scholar Back to article
“2023 NSDUH Detailed Tables | CBHSQ Data.” Accessed: Jan. 28, 2025. [Online]. Available: https://www.samhsa.gov/data/report/2023-nsduh-detailed-tables
Search in Google Scholar Back to article
R. F. Simpson et al., “Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study,” Lancet Public Health, vol. 4, no. 1, pp. e41–e48, Jan. 2019, doi: 10.1016/S2468-2667(18)30230-5.
Open DOI Search in Google Scholar Back to article
N. Torp et al., “Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3),” Liver Int. Off. J. Int. Assoc. Study Liver, vol. 42, no. 1, pp. 92–101, Jan. 2022, doi: 10.1111/liv.15120.
Open DOI Search in Google Scholar Back to article
U. Becker, M. Grønbaek, D. Johansen, and T. I. A. Sørensen, “Lower risk for alcohol-induced cirrhosis in wine drinkers,” Hepatol. Baltim. Md, vol. 35, no. 4, pp. 868–875, Apr. 2002, doi: 10.1053/jhep.2002.32101.
Open DOI Search in Google Scholar Back to article
S. Buch et al., “A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis,” Nat. Genet., vol. 47, no. 12, pp. 1443–1448, Dec. 2015, doi: 10.1038/ng.3417.
Open DOI Search in Google Scholar Back to article
J. B. Whitfield et al., “A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers,” J. Hepatol., vol. 76, no. 2, pp. 275–282, Feb. 2022, doi: 10.1016/j.jhep.2021.10.005.
Open DOI Search in Google Scholar Back to article
F. Stickel et al., “Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis,” Am. J. Gastroenterol., vol. 113, no. 10, pp. 1475–1483, Oct. 2018, doi: 10.1038/s41395-018-0041-8.
Open DOI Search in Google Scholar Back to article
Y. Chang et al., “Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis,” Hepatol. Baltim. Md, vol. 71, no. 3, pp. 861–873, Mar. 2020, doi: 10.1002/hep.30867.
Open DOI Search in Google Scholar Back to article
T. B. Peeraphatdit et al., “A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality,” Mayo Clin. Proc., vol. 95, no. 12, pp. 2612–2620, Dec. 2020, doi: 10.1016/j.mayocp.2020.04.046.
Open DOI Search in Google Scholar Back to article
A. Moriya et al., “Roles of alcohol consumption in fatty liver: a longitudinal study,” J. Hepatol., vol. 62, no. 4, pp. 921–927, Apr. 2015, doi: 10.1016/j.jhep.2014.11.025.
Open DOI Search in Google Scholar Back to article
F. Åberg, J. Helenius-Hietala, P. Puukka, M. Färkkilä, and A. Jula, “Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population,” Hepatol. Baltim. Md, vol. 67, no. 6, pp. 2141–2149, Jun. 2018, doi: 10.1002/hep.29631.
Open DOI Search in Google Scholar Back to article
E. Alvarado-Tapias et al., “Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD,” Obes. Surg., vol. 33, no. 5, pp. 1494–1505, May 2023, doi: 10.1007/s11695-023-06490-w.
Open DOI Search in Google Scholar Back to article
M.-C. Tsai et al., “Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus–Related Cirrhosis,” JAMA Netw. Open, vol. 5, no. 7, p. e2223511, Jul. 2022, doi: 10.1001/jamanetworkopen.2022.23511.
Open DOI Search in Google Scholar Back to article
L. Llamosas-Falcón et al., “Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis,” J. Hepatol., vol. 75, no. 3, pp. 536–546, Sep. 2021, doi: 10.1016/j.jhep.2021.04.018.
Open DOI Search in Google Scholar Back to article
L. M. Fletcher, J. L. Dixon, D. M. Purdie, L. W. Powell, and D. H. G. Crawford, “Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis,” Gastroenterology, vol. 122, no. 2, pp. 281–289, Feb. 2002, doi: 10.1053/gast.2002.30992.
Open DOI Search in Google Scholar Back to article
C. Yan, W. Hu, J. Tu, J. Li, Q. Liang, and S. Han, “Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease,” J. Transl. Med., vol. 21, no. 1, p. 300, May 2023, doi: 10.1186/s12967-023-04166-8.
Open DOI Search in Google Scholar Back to article
D. Zhang, Z. Liu, and F. Bai, “Roles of Gut Microbiota in Alcoholic Liver Disease,” Int. J. Gen. Med., vol. 16, pp. 3735–3746, Aug. 2023, doi: 10.2147/IJGM.S420195.
Open DOI Search in Google Scholar Back to article
C. Martino et al., “Acetate reprograms gut microbiota during alcohol consumption,” Nat. Commun., vol. 13, no. 1, p. 4630, Aug. 2022, doi: 10.1038/s41467-022-31973-2.
Open DOI Search in Google Scholar Back to article
L. Zhu, Y. Wang, C. Q. Pan, and H. Xing, “Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk,” Front. Pharmacol., vol. 14, p. 1258062, Aug. 2023, doi: 10.3389/fphar.2023.1258062.
Open DOI Search in Google Scholar Back to article
S. Lang et al., “Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis,” Hepatol. Baltim. Md, vol. 71, no. 2, pp. 522–538, Feb. 2020, doi: 10.1002/hep.30832.
Open DOI Search in Google Scholar Back to article
Y. Gao et al., “Porphyromonas gingivalis exacerbates alcoholic liver disease by altering gut microbiota composition and host immune response in mice,” J. Clin. Periodontol., vol. 50, no. 9, pp. 1253–1263, Sep. 2023, doi: 10.1111/jcpe.13833.
Open DOI Search in Google Scholar Back to article
S. Roychowdhury, B. Glueck, Y. Han, M. A. Mohammad, and G. A. M. Cresci, “A Designer Synbiotic Attenuates Chronic-Binge Ethanol-Induced Gut-Liver Injury in Mice,” Nutrients, vol. 11, no. 1, p. 97, Jan. 2019, doi: 10.3390/nu11010097.
Open DOI Search in Google Scholar Back to article
Q. Wang et al., “Microbial treatment of alcoholic liver disease: A systematic review and meta-analysis,” Front. Nutr., vol. 9, p. 1054265, 2022, doi: 10.3389/fnut.2022.1054265.
Open DOI Search in Google Scholar Back to article
A. Ajoolabady, H. Aslkhodapasandhokmabad, Y. Zhou, and J. Ren, “Epigenetic modification in alcohol-related liver diseases,” Med. Res. Rev., vol. 42, no. 4, pp. 1463–1491, Jul. 2022, doi: 10.1002/med.21881.
Open DOI Search in Google Scholar Back to article
D. Stols-Gonçalves et al., “Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review,” Cells, vol. 13, no. 22, p. 1893, Nov. 2024, doi: 10.3390/cells13221893.
Open DOI Search in Google Scholar Back to article
A. Lawan and A. M. Bennett, “Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism,” Trends Endocrinol. Metab. TEM, vol. 28, no. 12, pp. 868–878, Dec. 2017, doi: 10.1016/j.tem.2017.10.007.
Open DOI Search in Google Scholar Back to article
P. Melgar-Lesmes, M. Perramon, and W. Jiménez, “Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis,” Cells, vol. 8, no. 11, p. 1311, Oct. 2019, doi: 10.3390/cells8111311.
Open DOI Search in Google Scholar Back to article
Q. Cai, C. Gan, C. Tang, H. Wu, and J. Gao, “Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease,” Front. Pharmacol., vol. 12, p. 784591, Nov. 2021, doi: 10.3389/fphar.2021.784591.
Open DOI Search in Google Scholar Back to article
N. J. Shah, A. Royer, and S. John, “Alcoholic Hepatitis,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Aug. 30, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK470217/
Search in Google Scholar Back to article
M. Bou Saleh et al., “Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis,” J. Hepatol., vol. 75, no. 4, pp. 912–923, Oct. 2021, doi: 10.1016/j.jhep.2021.05.041.
Open DOI Search in Google Scholar Back to article
D. Blaya et al., “Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation,” Gut, vol. 65, no. 9, pp. 1535–1545, Sep. 2016, doi: 10.1136/gutjnl-2015-311314.
Open DOI Search in Google Scholar Back to article
M. Jouve, R. Carpentier, S. Kraiem, N. Legrand, and C. Sobolewski, “MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?,” Cancers, vol. 15, no. 23, p. 5557, Nov. 2023, doi: 10.3390/cancers15235557.
Open DOI Search in Google Scholar Back to article
J. Chen et al., “MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy,” J. Cell. Mol. Med., vol. 21, no. 12, pp. 3679–3692, Dec. 2017, doi: 10.1111/jcmm.13278.
Open DOI Search in Google Scholar Back to article
P. Saikia et al., “Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip,” Sci. Rep., vol. 7, no. 1, p. 15671, Nov. 2017, doi: 10.1038/s41598-017-15760-4.
Open DOI Search in Google Scholar Back to article
H. Chaudhry, A. Sohal, H. Iqbal, and M. Roytman, “Alcohol-related hepatitis: A review article,” World J. Gastroenterol., vol. 29, no. 17, pp. 2551–2570, May 2023, doi: 10.3748/wjg.v29.i17.2551.
Open DOI Search in Google Scholar Back to article
R. Jalan et al., “Toward an improved definition of acute-on-chronic liver failure,” Gastroenterology, vol. 147, no. 1, pp. 4–10, Jul. 2014, doi: 10.1053/j.gastro.2014.05.005.
Open DOI Search in Google Scholar Back to article
M. P. Ballester, R. Sittner, and R. Jalan, “Alcohol and Acute-on-Chronic Liver Failure,” J. Clin. Exp. Hepatol., vol. 12, no. 5, pp. 1360–1370, 2022, doi: 10.1016/j.jceh.2021.12.010.
Open DOI Search in Google Scholar Back to article
V. Rachakonda, R. Bataller, and A. Duarte-Rojo, “Recent advances in alcoholic hepatitis,” F1000Research, vol. 9, p. F1000 Faculty Rev-97, Feb. 2020, doi: 10.12688/f1000research.20394.1.
Open DOI Search in Google Scholar Back to article
L. L. Jophlin et al., “ACG Clinical Guideline: Alcohol-Associated Liver Disease,” Am. J. Gastroenterol., vol. 119, no. 1, pp. 30–54, Jan. 2024, doi: 10.14309/ajg.0000000000002572.
Open DOI Search in Google Scholar Back to article
C. L. Mendenhall, S. Anderson, R. E. Weesner, S. J. Goldberg, and K. A. Crolic, “Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis,” Am. J. Med., vol. 76, no. 2, pp. 211–222, Feb. 1984, doi: 10.1016/0002-9343(84)90776-9.
Open DOI Search in Google Scholar Back to article
V.-T. Enciu, P. M. Ologeanu, and C. Fierbinteanu-Braticevici, “Ultrasound Assessment of Sarcopenia in Alcoholic Liver Disease,” Diagn. Basel Switz., vol. 14, no. 17, p. 1891, Aug. 2024, doi: 10.3390/diagnostics14171891.
Open DOI Search in Google Scholar Back to article
K. Seppä, P. Laippala, and M. Saarni, “Macrocytosis as a consequence of alcohol abuse among patients in general practice,” Alcohol. Clin. Exp. Res., vol. 15, no. 5, pp. 871–876, Oct. 1991, doi: 10.1111/j.1530-0277.1991.tb00615.x.
Open DOI Search in Google Scholar Back to article
H. I. Lim and A. Cuker, “Thrombocytopenia and liver disease: pathophysiology and periprocedural management,” Hematol. Am. Soc. Hematol. Educ. Program, vol. 2022, no. 1, p. 296, Dec. 2022, doi: 10.1182/hematology.2022000408.
Open DOI Search in Google Scholar Back to article
A. Louvet et al., “Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids,” J. Hepatol., vol. 48, no. 3, pp. 465–470, Mar. 2008, doi: 10.1016/j.jhep.2007.10.010.
Open DOI Search in Google Scholar Back to article
D. W. CRABB et al., “Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia,” Gastroenterology, vol. 150, no. 4, pp. 785–790, Apr. 2016, doi: 10.1053/j.gastro.2016.02.042.
Open DOI Search in Google Scholar Back to article
J. Altamirano et al., “A histologic scoring system for prognosis of patients with alcoholic hepatitis,” Gastroenterology, vol. 146, no. 5, pp. 1231–1239.e1–6, May 2014, doi: 10.1053/j.gastro.2014.01.018.
Open DOI Search in Google Scholar Back to article
M. Lupşor-Platon et al., “Noninvasive assessment of liver steatosis using ultrasound methods,” Med. Ultrason., vol. 16, no. 3, pp. 236–245, Sep. 2014, doi: 10.11152/mu.2013.2066.163.1mlp.
Open DOI Search in Google Scholar Back to article
S. Maheshwari et al., “Imaging of Alcohol-Associated Liver Disease,” Am. J. Roentgenol., vol. 222, no. 1, p. e2329917, Jan. 2024, doi: 10.2214/AJR.23.29917.
Open DOI Search in Google Scholar Back to article
F. Janssens, N. de Suray, H. Piessevaux, Y. Horsmans, P. de Timary, and P. Stärkel, “Can transient elastography replace liver histology for determination of advanced fibrosis in alcoholic patients: a real-life study,” J. Clin. Gastroenterol., vol. 44, no. 8, pp. 575–582, Sep. 2010, doi: 10.1097/MCG.0b013e3181cb4216.
Open DOI Search in Google Scholar Back to article
A. Louvet et al., “The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids,” Hepatol. Baltim. Md, vol. 45, no. 6, pp. 1348–1354, Jun. 2007, doi: 10.1002/hep.21607.
Open DOI Search in Google Scholar Back to article
E. H. Forrest et al., “The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids,” Gut, vol. 56, no. 12, pp. 1743–1746, Dec. 2007, doi: 10.1136/gut.2006.099226.
Open DOI Search in Google Scholar Back to article
M. Sheth, M. Riggs, and T. Patel, “Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis,” BMC Gastroenterol., vol. 2, p. 2, 2002, doi: 10.1186/1471-230x-2-2.
Open DOI Search in Google Scholar Back to article
W. Dunn et al., “MELD accurately predicts mortality in patients with alcoholic hepatitis,” Hepatol. Baltim. Md, vol. 41, no. 2, pp. 353–358, Feb. 2005, doi: 10.1002/hep.20503.
Open DOI Search in Google Scholar Back to article
S. R. Atkinson et al., “In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers,” Off. J. Am. Coll. Gastroenterol. ACG, vol. 115, no. 11, p. 1857, Nov. 2020, doi: 10.14309/ajg.0000000000000912.
Open DOI Search in Google Scholar Back to article
J. Bissonnette et al., “A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis,” Hepatol. Baltim. Md, vol. 66, no. 2, pp. 555–563, Aug. 2017, doi: 10.1002/hep.29080.
Open DOI Search in Google Scholar Back to article
S. R. Atkinson et al., “Serum keratin 19 (CYFRA21-1) is a prognostic biomarker in severe alcoholic hepatitis,” Liver Int. Off. J. Int. Assoc. Study Liver, vol. 42, no. 5, pp. 1049–1057, May 2022, doi: 10.1111/liv.15218.
Open DOI Search in Google Scholar Back to article
A. Louvet et al., “Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study,” Hepatol. Baltim. Md, vol. 66, no. 5, pp. 1464–1473, Nov. 2017, doi: 10.1002/hep.29240.
Open DOI Search in Google Scholar Back to article
R. Liang, A. Liu, R. B. Perumpail, R. J. Wong, and A. Ahmed, “Advances in alcoholic liver disease: An update on alcoholic hepatitis,” World J. Gastroenterol., vol. 21, no. 42, p. 11893, Nov. 2015, doi: 10.3748/wjg.v21.i42.11893.
Open DOI Search in Google Scholar Back to article
J. Altamirano et al., “Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: Prediction and impact on long-term survival,” Hepatol. Baltim. Md, vol. 66, no. 6, pp. 1842–1853, Dec. 2017, doi: 10.1002/hep.29338.
Open DOI Search in Google Scholar Back to article
H. L. Bonkovsky et al., “A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition,” Am. J. Gastroenterol., vol. 86, no. 9, pp. 1209–1218, Sep. 1991.
Search in Google Scholar Back to article
A. M. Diehl et al., “Effect of parenteral amino acid supplementation in alcoholic hepatitis,” Hepatol. Baltim. Md, vol. 5, no. 1, pp. 57–63, 1985, doi: 10.1002/hep.1840050114.
Open DOI Search in Google Scholar Back to article
C. Mendenhall, G. A. Roselle, P. Gartside, and T. Moritz, “Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies,” Alcohol. Clin. Exp. Res., vol. 19, no. 3, pp. 635–641, Jun. 1995, doi: 10.1111/j.1530-0277.1995.tb01560.x.
Open DOI Search in Google Scholar Back to article
S. C. Bischoff et al., “ESPEN practical guideline: Clinical nutrition in liver disease,” Clin. Nutr. Edinb. Scotl., vol. 39, no. 12, pp. 3533–3562, Dec. 2020, doi: 10.1016/j.clnu.2020.09.001.
Open DOI Search in Google Scholar Back to article
G. Szabo et al., “IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis,” Hepatol. Baltim. Md, vol. 76, no. 4, pp. 1058–1068, Oct. 2022, doi: 10.1002/hep.32478.
Open DOI Search in Google Scholar Back to article
A. Dhanda et al., “Trace element deficiency is highly prevalent and associated with infection and mortality in patients with alcoholic hepatitis,” Aliment. Pharmacol. Ther., vol. 52, no. 3, pp. 537–544, Aug. 2020, doi: 10.1111/apt.15880.
Open DOI Search in Google Scholar Back to article
S. Støy, T. L. Laursen, L. L. Eriksen, H. Grønbæk, H. Vilstrup, and T. D. Sandahl, “No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation,” Clin. Transl. Gastroenterol., vol. 12, no. 2, p. e00306, Jan. 2021, doi: 10.14309/ctg.0000000000000306.
Open DOI Search in Google Scholar Back to article
C. Rongey and N. Kaplowitz, “Current concepts and controversies in the treatment of alcoholic hepatitis,” World J. Gastroenterol. WJG, vol. 12, no. 43, pp. 6909–6921, Nov. 2006, doi: 10.3748/wjg.v12.i43.6909.
Open DOI Search in Google Scholar Back to article
S. M. Shasthry and S. K. Sarin, “New treatment options for alcoholic hepatitis,” World J. Gastroenterol., vol. 22, no. 15, pp. 3892–3906, Apr. 2016, doi: 10.3748/wjg.v22.i15.3892.
Open DOI Search in Google Scholar Back to article
S. Singh et al., “Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis,” Gastroenterology, vol. 149, no. 4, pp. 958–970.e12, Oct. 2015, doi: 10.1053/j.gastro.2015.06.006.
Open DOI Search in Google Scholar Back to article
G. Szabo et al., “IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis,” Hepatol. Baltim. Md, vol. 76, no. 4, pp. 1058–1068, Oct. 2022, doi: 10.1002/hep.32478.
Open DOI Search in Google Scholar Back to article
S. Gawrieh et al., “Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis,” J. Hepatol., vol. 80, no. 5, pp. 684–693, May 2024, doi: 10.1016/j.jhep.2024.01.031.
Open DOI Search in Google Scholar Back to article
A. Marot, A. K. Singal, C. Moreno, and P. Deltenre, “Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials,” JHEP Rep., vol. 2, no. 5, p. 100139, Jun. 2020, doi: 10.1016/j.jhepr.2020.100139.
Open DOI Search in Google Scholar Back to article
A. Louvet et al., “Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study,” Lancet Gastroenterol. Hepatol., vol. 7, no. 5, pp. 416–425, May 2022, doi: 10.1016/S2468-1253(21)00430-1.
Open DOI Search in Google Scholar Back to article
B. P. Lee et al., “Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis,” Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc., vol. 20, no. 2, pp. 409–418.e5, Feb. 2022, doi: 10.1016/j.cgh.2020.11.024.
Open DOI Search in Google Scholar Back to article
C. A. Marroni et al., “Liver transplantation and alcoholic liver disease: History, controversies, and considerations,” World J. Gastroenterol., vol. 24, no. 26, pp. 2785–2805, Jul. 2018, doi: 10.3748/wjg.v24.i26.2785.
Open DOI Search in Google Scholar Back to article
R. Bañares et al., “Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial,” Hepatol. Baltim. Md, vol. 57, no. 3, pp. 1153–1162, Mar. 2013, doi: 10.1002/hep.26185.
Open DOI Search in Google Scholar Back to article
S. E. Kumar et al., “Low Volume Plasma Exchange and Low Dose Steroid Improve Survival in Patients With Alcohol-Related Acute on Chronic Liver Failure and Severe Alcoholic Hepatitis - Preliminary Experience,” J. Clin. Exp. Hepatol., vol. 12, no. 2, pp. 372–378, 2022, doi: 10.1016/j.jceh.2021.07.010.
Open DOI Search in Google Scholar Back to article
A. Pande et al., “Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial,” Hepatol. Int., vol. 17, no. 1, pp. 249–261, Feb. 2023, doi: 10.1007/s12072-022-10438-0.
Open DOI Search in Google Scholar Back to article
Z. DeFilipp et al., “Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant,” N. Engl. J. Med., vol. 381, no. 21, pp. 2043–2050, Nov. 2019, doi: 10.1056/NEJMoa1910437.
Open DOI Search in Google Scholar Back to article
J. H. Jung, S.-E. Kim, K. T. Suk, and D. J. Kim, “Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota,” Front. Med., vol. 9, Jul. 2022, doi: 10.3389/fmed.2022.913842.
Open DOI Search in Google Scholar Back to article

Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis

Abstract

Paradigm

My account